Possibilities to Limit the Values of Clinical and Biochemical Parameters in Experimental Arterial Hypertension-Reference-Cited by-同舟云学术

Possibilities to Limit the Values of Clinical and Biochemical Parameters in Experimental Arterial Hypertension

Published:2018-11-14 Issue: Volume: Page:
ISSN:
Container-title:Blood Pressure - From Bench to Bed
language:
Short-container-title:

Author:

Ciocoiu Manuela,Diaconescu Bogdan Mihail,Badescu Codruta

Publisher

InTech

Link

http://www.intechopen.com/download/pdf/57707

Reference56 articles.

1. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfab C, Handler J, Lackland DT, et al. Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth Joint National Commitee (JNC 8). Journal of the American Medical Association. 2014;311(5):507-520. DOI: 10.1001/jama.2013.284427

2. Weber MA, Giles TD. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: Do we need a more comprehensive strategy? Reviews in Cardiovascular Medicine. 2006;7(2):45-54. PMID: 16915123

3. Pai PY, Muo CH, Sung FC, Ho HC, Lee YT. Angiotensin receptor blockers (ARB) outperform angiotensin-converting enzyme (ACE) inhibitors on ischemic stroke prevention in patients with hypertension and diabetes—A real-world population study in Taiwan. International Journal of Cardiology. 2016;215:114-119. DOI: 10.1016/j.ijcard.2016.04.096

4. Fisher ND, Hollenberg NK. Renin inhibition: What are the therapeutic opportunities? Journal of the American Society of Nephrology. 2005;16(3):592-599. DOI: 10.1681/ASN.2004100874

5. Azizi M, Webb R, Nussberger J, Hollenberg NK. Renin inhibition with aliskiren: Where are we now, and where are we going? Journal of Hypertension. 2006;24(2):243-256. DOI: 10.1097/01.hjh.0000202812.72341.99